Rickettsia slovaca and R. raoultii in Tick-borne Rickettsioses by Parola, Philippe et al.
Rickettsia slovaca 
and R. raoultii   
in Tick-borne   
Rickettsioses 
Philippe Parola, Clarisse Rovery,  
Jean Marc Rolain, Philippe Brouqui,  
Bernard Davoust, and Didier Raoult
Tick-borne  lymphadenopathy  (TIBOLA),  also  called 
Dermacentor-borne necrosis erythema and lymphadenopa-
thy (DEBONEL), is defined as the association of a tick bite, 
an inoculation eschar on the scalp, and cervical adenopa-
thies. We identified the etiologic agent for 65% of 86 patients   
with TIBOLA/DEBONEL as either Rickettsia slovaca (49/86, 
57%) or R. raoultii (7/86, 8%).
I
n 1968, Rickettsia slovaca, a spotted fever group (SFG) 
rickettsia,  was  isolated  from  Dermacentor  marginatus 
ticks in the former Czechoslovakia before being detected 
in D. marginatus or D. reticulatus ticks throughout Europe 
(Figure 1) (1). In 1997, R. slovaca was described as a human 
pathogen and an agent of tick-borne lymphadenopathy (TI-
BOLA) (2). This syndrome, also called Dermacentor-borne 
necrosis erythema and lymphadenopathy (DEBONEL), is 
defined as the association of a tick bite, an inoculation eschar 
on the scalp, and cervical lymphadenopathies (3).
Since  1999,  several  rickettsial  genotypes,  called 
DnS14, DnS28, and RpA4, have been detected in Derma-
centor spp. ticks throughout Europe (Figure 1). Isolates 
have been obtained and shown to belong to a unique new 
SFG rickettisia species named R. raoultii (4). In 2002, R. 
raoultii DNA was detected in a D. marginatus tick taken 
from the scalp of a patient in whom TIBOLA/DEBONEL 
developed in France (4). Moreover, DNA of what is now 
known to be R. raoultii has been found in the blood of 1 
patient  with  TIBOLA/DEBONEL  (5).  The  goal  of  this 
study was to identify the rickettsial agents in patients with 
TIBOLA/DEBONEL symptoms and in those who had an 
isolated tick bite on the scalp.
The Study
We  included  all  patients  with  TIBOLA/DEBONEL 
symptoms (Figure 2) and those who had an isolated tick 
bite on the scalp without any symptoms from whom sam-
ples (serum, skin biopsy, or ticks harvested from the scalp) 
were received at our laboratory from January 2002 through 
December 2007. Epidemiologic and clinical data were col-
lected retrospectively. The study was approved by the eth-
ics committee of the Medicine School of Marseille under 
reference 08-008.
Immunoglobulin (Ig) G and IgM titers against rickett-
sial antigens were estimated by microimmunofluorescent 
assay; results were verified by Western blot and cross-
absorption studies (3). Ticks found on persons and skin 
biopsy  specimens  were  cultured  on  human  embryonic 
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Figure 1. Dermacentor reticulatus, the ornate dog tick (A) (female, 
left;  male,  right),  and  D.  marginatus,  the  ornate  sheep  tick  (B) 
(engorged female, left; unfed female, center; male, right; scale bar 
= 1 cm), and their distribution. D. marginatus is most frequently 
found in Mediterranean areas of Europe with dense bush and tree 
cover and is common under oak and pine vegetation. It also has 
a  restricted  distribution  in  North Africa,  in  the  cooler  and  more 
humid  areas  associated  with  the Atlas  Mountains. Adults  infest 
large  mammals  such  as  sheep,  cattle,  goats,  and  wild  boars. 
Larvae and nymphs feed mostly on small mammals and medium 
sized carnivores. D. reticulatus is most frequently found in colder 
northern areas of western Europe and the former Soviet Union, 
with high humidity and mild winters. D. reticulatus is primarily a 
tick of dogs and carnivores, but it can be found on ungulates such 
as sheep, cattle, and horses (9). D. marginatus and D. reticulatus 
have been suggested as reservoirs of R. slovaca and R. raoultii, 
which are maintained in ticks through transstadial and transovarial 
transmission.  Therefore,  the  geographic  distribution  of  these 
rickettsiae likely parallels that of Dermacentor ticks (C). lung cells (6). These samples were also used to amplify 
and identify outer membrane protein A–encoding gene 
fragments of rickettsiae by PCR (3). Also, the so-called 
suicide  PCR-assay  was  used  with  acute-phase  serum   
samples (1).
Among 98 study patients, 86 were classified as TIBO-
LA/DEBONEL  patients.  Twelve  (12.2%)  patients  made 
up the second group with an isolated tick bite. All but 1 
patient, who was bitten in Belgium, were bitten in France. 
Tick bites more frequently occurred from February through 
May (50/86, 58.1%). Because of results of serologic tech-
niques, we could conclude that 66 (84.6%) of 78 TIBOLA/
DEBONEL patients with obtained serum specimens had a 
recent rickettsial disease. Western blot and cross-adsorp-
tion analyses enabled detection of antibodies specifically 
directed against R. slovaca and R. raoultii in 34 and 4 pa-
tients, respectively (online Appendix Table, available from 
www.cdc.gov/EID/content/15/7/1105-appT.htm).
Two patients who were infected with R. slovaca were 
found to be co-infected with Coxiella burnetii in an acute 
form of Q fever. Serologic testing was performed in 12 
patients with isolated tick bites, and results were negative 
in all cases. A total of 19 skin biopsy specimens were ob-
tained. Four R. slovaca infections were diagnosed by reg-
ular PCR, and 3 isolates of this rickettsia were obtained. 
The suicide PCR on acute-phase serum samples identified 
1 additional case of R. slovaca infection. Because of mo-
lecular tools and culture, 6 patients received the diagnosis 
of an R. slovaca infection, including 5 who did not receive 
a diagnosis by serologic assays (online Appendix Table). 
Ticks removed from 28 TIBOLA/DEBONEL patients con-
sisted of 23 D. marginatus (88.4%), 2 Dermacentor spp., 
1 Haemaphysalis punctata, and 2 that were not identified. 
Overall, the tick studies enabled us to suggest the diagnosis 
of R. slovaca and R. raoultii infections in 10 and 3 patients, 
respectively, whose conditions were not diagnosed with 
previous tests (online Appendix Table).
All DNA sequences obtained showed 100% identity 
with R. raoultii or R. slovaca, excluding the coexistence 
of several rickettsiae in the corresponding samples. Ac-
cording to our investigations, 49 (57%) of 86 patients with 
TIBOLA/DEBONEL had probable or certain R. slovaca 
infections, and 7 (8%) of 86 had probable R. raoultii infec-
tions. The characteristics of these patients are shown in the 
Table.
Conclusions
We  report  86  patients  with  TIBOLA/DEBONEL; 
this group includes 14 patients whose conditions had been 
preliminarily reported (7). We also describe several cases 
caused by the emerging pathogen R. raoultii (4), includ-
ing patients with indirect molecular evidence of infection 
because the pathogen was detected in the ticks that had bit-
ten them. Original findings also include facial edema as a 
new clinical feature in TIBOLA/DEBONEL, and the report 
of the second patient co-infected with R. slovaca and C. 
burnetii (8). Because acute Q fever, a worldwide zoono-
sis, may be asymptomatic, we recommend that patients in-
fected with tick-borne pathogens also undergo testing for 
concurrent infections with C. burnetii.
No TIBOLA/DEBONEL cases were recorded during 
the warmest summer months; peak incidence occurred dur-
ing March–May and during September–November, linked 
with the activity of Dermacentor ticks in Europe (Figure 1) 
(9). However, to date, we have no explanation for the find-
ing that children and women are at higher risk for TIBOLA/
DEBONEL or why D. marginatus and D. reticulatus ticks 
prefer to bite persons on the scalp. A possible explanation 
could be that Dermacentor ticks usually bite hairy domes-
tic and wild animals and the longer hair of women and chil-
dren may attract them.
One of the most remarkable findings of this work is the 
proportional importance of R. slovaca in TIBOLA/DEB-
ONEL patients, compared with R. raoultii. In 2006, Ibarra 
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Figure 2. Typical signs of TIBOLA (tick-borne lymphadenopathy)/DEBONEL (Dermacentor-borne necrosis erythema and lymphadenophy). 
Here, infections were caused by Rickettsia slovaca, resulting in cervical lymphadenopathy (left panel, arrow), inoculation on the scalp 
(middle panel), and residual alopecia 4 weeks later (right panel).Tick-borne Rickettsioses
et al. reported on 14 persons in Spain who had a D. margin-
atus tick attached to the scalp (10). All ticks were found to 
be infected by rickettsiae: 8 (58%) were infected by R. slo-
vaca, and 6 (42%) by R. raoultii. In 10 of the patients, TI-
BOLA/DEBONEL symptoms developed, including in all 8 
of the patients who had been bitten by a tick infected by R. 
slovaca and in 2 of the 6 patients who had been bitten by 
a tick infected by R. raoultii. R. slovaca was more signifi-
cantly associated with TIBOLA/DEBONEL patients than 
was R. raoultii (p<0.05) (10). Here, focusing on the studies 
of ticks removed from TIBOLA/DEBONEL patients, we 
found that 12 of 19 ticks harbored R. slovaca, whereas only 
3 of 19 harbored R. raoultii (p = 0.047). In the patients with 
asymptomatic tick bites, from whom 9 ticks were obtained, 
all ticks positive by PCR harbored R. raoultii.
Moreover, R. raoultii seems to be more highly preva-
lent in D. marginatus and D. reticulatus ticks in nature than 
is R. slovaca. Although comparing field surveys of ticks 
is difficult because of the sampling methods, the sizes of 
the samples, and the potential PCR inhibitors, R. raoultii 
has been more frequently detected in D. marginatus ticks 
than has R. slovaca. In southeastern Spain, 73% of 101 D. 
marginatus ticks were infected by R. raoultii and 27% by 
R. slovaca (11). Similar differences have been shown in 
Germany, Portugal, the Netherlands, and Spain (12–15). 
Although interpreting these data definitively is difficult, the 
recurrence of similar published results by different teams 
suggests that exposure to R. raoultii through the bite of a 
Dermacentor spp. tick is likely more frequent than expo-
sure to R. slovaca. However, more cases of R. slovaca in-
fection have been recorded, which suggests that R. raoultii 
is less pathogenic.
TIBOLA/DEBONEL is a newly recognized disease, 
and its incidence is likely underestimated. In our labora-
tory, TIBOLA/DEBONEL is the most frequently reported 
rickettsial disease, except during the dry summer period. 
Doxycycline remains the treatment of choice, with new 
macrolides as alternative treatments (1). Although we re-
port 6 more cases of R. raoultii infection in addition to the 
2 recently reported (4,5), this Dermacentor-borne rickettsia 
seems to be less pathogenic than R. slovaca.
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